18F]FDG PET/CT for predicting triple-negative breast cancer outcomes after neoadjuvant chemotherapy with or without pembrolizuma

Purpose: To determine if pretreatment [18F]FDG PET/CT could contribute to predicting complete pathological complete response (pCR) in patients with early-stage triple-negative breast cancer (TNBC) undergoing neoadjuvant chemotherapy with or without pembrolizumab. Methods: In this retrospective bicen...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	European journal of nuclear medicine and molecular imaging 2023, Vol.50 (13), p.4024-4035
Hauptverfasser:	Seban, Romain David, Arnaud, Emilie, Loirat, Delphine, Cabel, Luc, Cottu, Paul Henri, Djerroudi, Lounes, Hescot, Ségolène, Loap, Pierre, Bonneau, Claire, Bidard, François Clément, Huchet, Virginie, Jehanno, Nina, Berenbaum, Arnaud, Champion, Laurence, Buvat, Ir̀ene
Format:	Artikel
Sprache:	eng
Schlagworte:	Cancer Life Sciences
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!